Dr Reddy’s Custom Pharmaceutical Services: A Tailor-Made Breakthrough Strategy in Pharma Offshoring?

Overwhelmed by escalating pressures to reduce health care costs, elevated R&D budgets, diminishing numbers of new drugs as against leading blockbuster drugs going off-patent, coupled with numerous regulatory challenges in the West, global pharma companies were increasingly exploring low-cost options but highly skilled destinations for offshoring their pharmaceutical services in order to attain maximum efficiency and productivity. Consequently, in the race for survival, major pharma and biotech companies were seeking to keep hold of their drug discovery and portfolio management, while outsourcing their manufacturing and research processes, thus developing a cost-effective business model in the highly competitive arena and substantiating an ever-growing demand for contract research and contract manufacturing services.